Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Food and Drug Administration (FDA) - November 5, 2003
In June 2003, FDA's OWH solicited proposals from women's health research networks capable of conducting clinical studies. FDA reviewed the proposals it received and awarded contracts to Boston University, Indiana University, Tulane University, University of Illinois at Chicago, University of Wisconsin, University of Arizona, and University of Washington. These institutions will conduct research studies to address to specific questions in women's health over the next five years.
"The research conducted at these leading institutions will provide valuable insight into how FDA can advance its current regulatory approaches to improve women's health," said FDA Commissioner Mark B. McClellan, M.D., Ph.D. For example, the FDA's contract with the University of Arizona will fund research to help determine if pregnancy changes the activity of the antidepressant medication sertraline. A second study, at Boston University, will look at factors influencing blood glucose monitoring for diabetes via fingertip vs. drawing blood samples from other locations on the body in both women and men.
"These contracts demonstrate how FDA is leveraging its resources by forming partnerships with academic institutions to identify and address important women's health issues," said Susan F. Wood, Ph.D., Assistant Commissioner for Women's Health.
Under the terms of the contracts, over the next five years, the FDA will be able to award competitive, women's health related projects to one or more of the seven institutions.
####
P03-91 November 5, 2003
Media Inquiries: 301-827-6242 Consumer Inquiries: 888-INFO-FDA
031105
FD031104
SOURCE: Food and Drug Administration (FDA).
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .